[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-352135-105":59,"doc-detail-352135-en":134},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":127,"head_meta":129,"extra_data":131,"updated_unix":133},105,"en","an-in-vitro-and-in-vivo-assessment-of-the-anti-breast-cancer-activity-of-erythrina-excelsa-baker-fabaceae-bark-extracts-original-article-anticancer-evaluation-in-vitro-and-in-vivo","An In Vitro and In Vivo Assessment of the Anti-Breast Cancer Activity of Erythrina excelsa Baker (Fabaceae) Bark Extracts - Original Article - Anticancer evaluation in vitro and in vivo","","Breast cancer remains a high-mortality concern among Cameroonian women, and Erythrina excelsa bark is traditionally used for medicinal management of various conditions including cancer. This study assessed phytochemical composition, antioxidant activity, and anticancer effects of E. excelsa bark extracts using in vitro and in vivo models. Phytochemical profiling and antioxidant assays (DPPH, FRAP) were combined with cytotoxicity, apoptosis, and cell-cycle arrest testing in MCF-7 and MDA-MB-231 cells. In rats with DMBA-induced mammary carcinogenesis, the extracts reduced tumor incidence, CA 15–3, pro-inflammatory cytokines, oxidative stress, and hepatic/renal toxicity while enhancing antioxidant defenses.",{"@graph":69,"@context":126},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/an-in-vitro-and-in-vivo-assessment-of-the-anti-breast-cancer-activity-of-erythrina-excelsa-baker-fabaceae-bark-extracts-original-article-anticancer-evaluation-in-vitro-and-in-vivo/352135/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/an-in-vitro-and-in-vivo-assessment-of-the-anti-breast-cancer-activity-of-erythrina-excelsa-baker-fabaceae-bark-extracts-original-article-anticancer-evaluation-in-vitro-and-in-vivo/352135.png","ImageObject",300,407,{"name":92,"@type":93},"hdkawk","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118,122],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main objective of the study on Erythrina excelsa bark?","Question",{"text":112,"@type":113},"To evaluate the phytochemical composition, antioxidant properties, and anticancer activity of Erythrina excelsa bark extracts both in vitro and in vivo.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which breast cancer cell lines and assays were used for in vitro evaluation?",{"text":117,"@type":113},"MCF-7 and MDA-MB-231 cell lines were used to test cytotoxicity, apoptosis, and cell-cycle arrest, while antioxidant assays included DPPH and FRAP.",{"name":119,"@type":110,"acceptedAnswer":120},"How was anticancer efficacy assessed in vivo?",{"text":121,"@type":113},"In vivo chemopreventive efficacy was evaluated in 42 female rats using a DMBA-induced mammary carcinogenesis model, with treatment delivered daily for 20 weeks.",{"name":123,"@type":110,"acceptedAnswer":124},"What biological effects were observed after treatment with the bark extracts?",{"text":125,"@type":113},"The extracts inhibited cancer cell growth in a dose-dependent manner, induced apoptosis, promoted G2/M cell-cycle arrest, reduced tumor parameters and inflammatory cytokines, strengthened antioxidant defenses, and mitigated hepatic and renal toxicity without evident systemic side effects.","https://schema.org",{"og:url":83,"og:type":128,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":130,"canonical":83},"index,follow",{"doc_id":132,"site_id":62},352135,1790125993,{"code":4,"msg":5,"data":135},{"doc_id":132,"user_id":136,"nickname":92,"user_avatar":137,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":56,"language":143,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":144,"faqs":145,"seo_title":146,"seo_description":67,"update_tm":147,"read_time":148,"preview_page_count":19,"preview_urls":149},3985747859855,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Cancer Reports  \nORIGINAL ARTICLE  OPEN ACCESS   \nAn In Vitro and In Vivo Assessment of the Anti-Breast Cancer Activity of Erythrina excelsa Baker (Fabaceae) Bark Extracts  \nJonas Walantini1 | Marius Trésor Kemegne Sipping2  | Merline Nguedia Ymele1  | Roland Nhouma Rebe1 | Joël Abel Gbaweng Yaya3 | Derek Tantoh Ndinteh4  | Dieudonné Njamen2 | Stéphane Zingue4,5   \n1Department of Biological Sciences, Faculty of Science, University of Maroua, Maroua, Cameroon | 2Department of Animal Biology and Physiology, Faculty of Science, University of Yaoundé 1, Yaoundé, Cameroon | 3Department of Chemistry, Faculty of Science, University of Ngaoundere, Ngaoundere, Cameroon | 4Centre for Natural Product Research, Department of Chemical Sciences, University of Johannesburg, Johannesburg, South Africa | 5Department of Pharmacotoxicology and Pharmacokinetics, Faculty of Medicine and Biomedical Sciences, University of Yaoundé 1, Yaoundé, Cameroon  \nCorrespondence: Stéphane Zingue ([stephane.zingue@fmsb-uy1.cm](stephane.zingue@fmsb-uy1.cm))  \nReceived: 8 December 2025 | Revised: 6 July 2026 | Accepted: 27 July 2026  \nKeywords: anti-inflammatory | antioxidant | apoptosis | breast cancer | cell cycle | DMBA | Erythrina excelsa  \nABSTRACT  \nBackground: Breast cancer remains a topic of interest due to its high mortality rate among Cameroonian women. The barks of Erythrina excelsa are traditionally used for medicinal purposes in the management of various conditions including cancer. Aims: This study evaluated the phytochemical composition, antioxidant properties, and anticancer effects of Erythrina excelsa bark extract in vitro and in vivo.  \nMethods and Results: Phytochemical profiling and antioxidant assays (DPPH, FRAP) were conducted to determine secondary metabolite content and free radical scavenging capacity. Cytotoxicity, apoptosis, and cell cycle arrest were assessed in MCF-7 and MDA-MB-231 breast cancer cell lines. In vivo chemopreventive efficacy was evaluated using a DMBA-induced mammary carcinogenesis in 42 female rats aged 55 to 65 days (~100 g), except the normal group (n = 7) . The normal (NOR) and negative (DMBA) groups were treated daily with the vehicle (2% ethanol in distilled water) while the positive (Tamox) and test groups received tamoxifen (3.3 mg/kg) and Erythrina excelsa extract (75, 150, 300 mg/kg BW), respectively for 20 weeks. Tumor parameters, serum biomarkers (CA 15–3, cytokines), oxidative stress markers, hematological and biochemical indices, and organ toxicity were assessed. As results, both aqueous (AE) and ethanolic (EE) extracts ofE. excelsa inhibited the growth of MCF-7 and MDA-MB-231 breast cancer cells in a dose-dependent manner after 24 h, induced apoptosis, and promoted G2/M cell cycle arrest. In vivo, E. excelsa aqueous extract (AE) significantly reduced tumor incidence, volume, and weight in a DMBA-induced mammary carcinogenesis rat model, while lowering serum CA15-3 and pro-inflammatory cytokines (IFN-γ, TNF-α, IL-6, IL-12) . Treatment also enhanced antioxidant defenses (SOD, catalase, GSH), reduced lipid peroxidation (MDA), improved hematological and biochemical parameters, and mitigated DMBA-induced hepatic and renal toxicity, without evidence of systemic side effects.  \n\n| Abbreviations: ALT, alanine transaminase; AST, aspartate aminotransferase; BSA, bovine serum albumin; CA 15–3, cancer antigen 15–3; DMBA, 7,12-dimethylbenz(a) anthracene; DNA, deoxyribonucleic acid; ELISA, enzyme-linked immunosorbent assay; EMT, epithelial to mesenchymal transition; FBS, fetal bovine serum; FRAP, ferric reducing antioxidant power; HRP, horseradish peroxidase; IFN-γ, interferon-gamma; IL, interleukins; JNK, N-terminal kinase c-Jun; MDA, malondialdehyde; NHC, national herbarium of cameroon; PAH, polycyclic aromatic hydrocarbons; PBS, phosphate-buffered saline; PI, propidium iodide; RBCs, red blood cells; ROS, reactive oxygen species; RT, room temperature; SERM, selective estrogen receptor modulator; TFC, total flavonoid","cbCaid61t005EQ0q","https://ap.wps.com/l/cbCaid61t005EQ0q","pdf",3019772,"English","# Abstract\n## Background\n## Aims\n## Methods and Results\n## Conclusion\n# Introduction\n## Cancer burden and therapeutic limitations","[{\"question\":\"What is the main objective of the study on Erythrina excelsa bark?\",\"answer\":\"To evaluate the phytochemical composition, antioxidant properties, and anticancer activity of Erythrina excelsa bark extracts both in vitro and in vivo.\"},{\"question\":\"Which breast cancer cell lines and assays were used for in vitro evaluation?\",\"answer\":\"MCF-7 and MDA-MB-231 cell lines were used to test cytotoxicity, apoptosis, and cell-cycle arrest, while antioxidant assays included DPPH and FRAP.\"},{\"question\":\"How was anticancer efficacy assessed in vivo?\",\"answer\":\"In vivo chemopreventive efficacy was evaluated in 42 female rats using a DMBA-induced mammary carcinogenesis model, with treatment delivered daily for 20 weeks.\"},{\"question\":\"What biological effects were observed after treatment with the bark extracts?\",\"answer\":\"The extracts inhibited cancer cell growth in a dose-dependent manner, induced apoptosis, promoted G2/M cell-cycle arrest, reduced tumor parameters and inflammatory cytokines, strengthened antioxidant defenses, and mitigated hepatic and renal toxicity without evident systemic side effects.\"}]","An In Vitro and In Vivo Assessment of the Anti-Breast Cancer Activity of Erythrina excelsa Baker (Fabaceae) Bark Extracts - Original Article - Anticancer evaluation in vitro and in vivo | PDF",1790097846,48,[150,154,158,162],{"page_no":8,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/de7de2bcef1e9ff8cd6589b2f65758d4.webp",983,1291,{"page_no":14,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/49ef631029f0eb1fe7df492891f924c2.webp",982,1290,{"page_no":81,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9017857e07f5ed3b7f26769881954e62.webp",981,1289,{"page_no":19,"url":163,"width":164,"height":165},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2255a90eabebf37f6a607001e3363154.webp",980,1287]